chr19-48398452-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM2BP4_ModerateBP6_ModerateBP7BS1
The NM_000836.4(GRIN2D):c.60G>A(p.Leu20Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000202 in 148,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
GRIN2D
NM_000836.4 synonymous
NM_000836.4 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 1.32
Publications
0 publications found
Genes affected
GRIN2D (HGNC:4588): (glutamate ionotropic receptor NMDA type subunit 2D) N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. NMDA channel has been shown to be involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. NMDA receptor channels are heteromers composed of the key receptor subunit NMDAR1 (GRIN1) and 1 or more of the 4 NMDAR2 subunits: NMDAR2A (GRIN2A), NMDAR2B (GRIN2B), NMDAR2C (GRIN2C), and NMDAR2D (GRIN2D). [provided by RefSeq, Mar 2010]
GRIN2D Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 46Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 19-48398452-G-A is Benign according to our data. Variant chr19-48398452-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 2998915.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.32 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0000202 (3/148824) while in subpopulation AFR AF = 0.0000731 (3/41054). AF 95% confidence interval is 0.0000194. There are 0 homozygotes in GnomAd4. There are 0 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000202 AC: 3AN: 148824Hom.: 0 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
3
AN:
148824
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 946406Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 445684
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
946406
Hom.:
Cov.:
27
AF XY:
AC XY:
0
AN XY:
445684
African (AFR)
AF:
AC:
0
AN:
18370
American (AMR)
AF:
AC:
0
AN:
4300
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
8876
East Asian (EAS)
AF:
AC:
0
AN:
13782
South Asian (SAS)
AF:
AC:
0
AN:
19376
European-Finnish (FIN)
AF:
AC:
0
AN:
10942
Middle Eastern (MID)
AF:
AC:
0
AN:
2216
European-Non Finnish (NFE)
AF:
AC:
0
AN:
834602
Other (OTH)
AF:
AC:
0
AN:
33942
GnomAD4 genome AF: 0.0000202 AC: 3AN: 148824Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 72554 show subpopulations
GnomAD4 genome
AF:
AC:
3
AN:
148824
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
72554
show subpopulations
African (AFR)
AF:
AC:
3
AN:
41054
American (AMR)
AF:
AC:
0
AN:
14982
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3436
East Asian (EAS)
AF:
AC:
0
AN:
5136
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
9218
Middle Eastern (MID)
AF:
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
AC:
0
AN:
66910
Other (OTH)
AF:
AC:
0
AN:
2042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Oct 16, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.